Gilead Agrees To Buy Kite Pharma, Leaping Into CAR-T Cancer Therapy

Aug 28, 2017, 10:57 AM by Michael Croft

STAT | Gilead agrees to buy Kite Pharma and its emerging line of CAR-T oncology therapies, which aim to harnesses the immune system to fight cancer.

August 28, 2017 | Gilead agrees to buy Kite Pharma and its emerging line of CAR-T oncology therapies, which aim to harnesses the immune system to fight cancer. STAT